IMVT Operating Cash Flow (Statement)
Immunovant Inc · Operating Cash Flow (Statement)
IMVT Operating Cash Flow (Statement)
Latest reported-$124.41Mperiod ending
IMVT Quarterly Cash from Operations (-$5.06M → -$124.41M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
IMVT operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -124,405,000 | |
| -95,059,000 | |
| -92,325,000 | |
| -102,515,000 | |
| -117,411,000 | |
| -110,637,000 | |
| -100,391,000 | |
| -88,647,000 | |
| -76,199,000 | |
| -59,699,000 | |
| -47,098,000 | |
| -60,060,000 | |
| -47,370,000 | |
| -55,793,000 | |
| -46,395,000 | |
| -20,186,000 | |
| -65,819,000 | |
| -32,956,000 | |
| -31,895,000 | |
| -20,047,000 | |
| -21,214,000 | |
| -22,496,000 | |
| -22,815,000 | |
| -24,218,000 | |
| -13,798,000 | |
| -23,050,000 | |
| -4,418 | |
| -301,502 | |
| -230,283 | |
| -450,000 | |
| -7,387,612 | |
| -3,445,553 | |
| -5,063,967 |